+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cetuximab chemoradiotherapy in HIV-associated anal cancer



Cetuximab chemoradiotherapy in HIV-associated anal cancer



Lancet. Oncology 18(2): E67




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059483792

Download citation: RISBibTeXText

PMID: 28017664

DOI: 10.1016/S1470-2045(16)30681-7


Related references

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial. Annals of Oncology 24(11): 2834-2838, 2014

Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial. RadioTherapy and Oncology 114(3): 415-416, 2015

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients. Targeted Oncology 13(1): 69-78, 2017

Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial. Journal of Clinical Oncology 35(7): 727-733, 2016

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205). Journal of Clinical Oncology 35(7): 718-726, 2017

Cetuximab plus chemoradiotherapy for anal carcinoma in immunocompetent patients does not change existing therapy standards : Results from the prospective, multicenter E3205 trial. Strahlentherapie und Onkologie 193(6): 508-509, 2017

Prediction of pathological response to preoperative chemoradiotherapy with cetuximab in rectal cancer. Journal of Clinical Oncology 26(15_suppl): 4095-4095, 2016

Use of cetuximab with definitive chemoradiotherapy for esophageal cancer results in decreased overall survival. Strahlentherapie und Onkologie 190(2): 233-234, 2014

In HPV-associated oropharyngeal cancer, chemoradiotherapy with cisplatin is superior to bioradiotherapy with cetuximab in terms of overall survival. Strahlentherapie und Onkologie 2019, 2019

A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer. Anticancer Research 32(9): 4019-4023, 2013

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. Lancet. Oncology 14(7): 627-637, 2013

Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer. Hematology/Oncology and Stem Cell Therapy 9(4): 147-153, 2016

Should cetuximab replace Cisplatin for definitive chemoradiotherapy in locally advanced head and neck cancer?. Journal of Clinical Oncology 31(2): 287-288, 2013

Chemoradiotherapy in anal cancer. Colorectal Disease 13 Suppl 1: 33-38, 2011

Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX. European Journal of Cancer 56: 115-121, 2016